A Landmark Clash: India's Supreme Court Navigates Life-Saving SMA Drugs, Patents, and Public Access
President Trump's Landmark Initiative to Tackle Skyrocketing Prescription Drug Costs
Gilead Secures Extended Runway for Blockbuster HIV Drug After Landmark Patent Settlements
America's Medicine Cabinet: Why US Dependence on Indian Pharma Has Soared by 70% Post-Pandemic
A Breath of Relief: How Trump's Drug Tariffs Spare India's Generic Pharma Giants
Trump's Tariff Tempest: Why a 100% Drug Tax Could Sink India's Pharma Giants and Ignite a US Healthcare Crisis
Trump's Bold Move: 100% Tariff on Branded Drugs Set to Shake Global Pharma, What It Means for India
India's Pharmaceutical Powerhouse Under Siege: Navigating Trump's Tariff Tempest
Trump's Tariff Twist: Generics Spared, But India's Export Horizon Remains Cloudy
Trump's Looming 100% Pharma Tariff: A Catastrophic Blow for India's Global Pharmacy?
A Game-Changer in HIV Treatment: Generic Drug Promises Unprecedented Affordability
The Enduring Saga of Drug Prices: Trump's Lingering Shadow on Healthcare Affordability
Lupin's Latest Triumph: US FDA Greenlight for HIV Drug Ignites Stock Rally
Trump's Rx for Disaster: Why a Paracetamol Ban Is a Perilous Prescription
India Delivers Major Blow to Novartis: Blockbuster Heart Drug Entresto Patent Revoked
Revolutionizing Healthcare: Government Unlocks Wider Access to Affordable Medicines with Bold New Policy
The Hidden Truth: America's Deep Reliance on Overseas Drug Manufacturing
Amneal Pharmaceuticals Secures Landmark FDA Approval for Generic Risperdal Consta
Trump's Tariff Tangle: Will His 10% Plan Hike Your Drug Costs?
Trump's Bold Plan to Slash Drug Costs with Tariffs: A Risky Bet for American Consumers?
The Unsung Heroes: How Indian Pharma Dodged Trump's Tariff Storm
Decoding the Paradox: Why Indian Pharma Stocks Are Plummeting Even After US Tariff Relief
A New Era for Actinic Keratosis Treatment: Extrovis and Dr. Reddy's Unveil Authorized Generic of CARAC® Cream